Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Feb 24;12(5):1829.
doi: 10.3390/jcm12051829.

Does Endometriosis Impact the Composition of Follicular Fluid in IL6 and AMH? A Case-Control Study

Affiliations

Does Endometriosis Impact the Composition of Follicular Fluid in IL6 and AMH? A Case-Control Study

Khadija Kacem-Berjeb et al. J Clin Med. .

Abstract

Objective: The aim of this study was to compare follicular liquid levels of IL6 and AMH in women with and without endometriosis and to evaluate their potential impact on ICSI outcomes.

Materials and methods: It is a prospective case-control study conducted on 25 women with proven endometriosis and 50 patients diagnosed with other causes of infertility. All these patients were candidates for ICSI cycles. Their follicular fluid was collected at the time of oocyte retrieval and used to evaluate IL-6 and AMH titers by electro-chemiluminescent immunoassay (Cobas e411-Roche).

Results: The IL-6 levels in follicular fluid were higher in the endometriosis group than in the control group (152.3 vs. 19.9 pg/mL; p = 0.02). The median level for AMH was 2.2 ± 1.88 ng/mL with no statistical difference between the two groups (2.2 vs. 2.7 ng/mL, p = 0.41). No significant correlation between the follicular IL6 and AMH levels was observed.

Conclusions: The oocyte quality seems to be preserved in patients with endometriosis with the adequate response to ovarian stimulation. High levels of follicular IL6 are in accordance with the inflammatory phenomenon of the disease; however, this increase has no impact on ICSI outcomes.

Keywords: AMH; IL6; IVF; endometriosis.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Burney R., Giudice L. Pathogenesis and pathophysiology of endometriosis. Fertil. Steril. 2012;98:511–519. doi: 10.1016/j.fertnstert.2012.06.029. - DOI - PMC - PubMed
    1. Shafrir A.L., Farland L.V., Shah D.K., Harris H.R., Kvaskoff M., Zondervan K., Missmer S.A. Risk for and consequences of endometriosis: A critical epidemiologic review. Best Pract. Res. Clin. Obs. 2018;51:1–15. doi: 10.1016/j.bpobgyn.2018.06.001. - DOI - PubMed
    1. Parazzini F., Esposito G., Tozzi L., Noli S., Bianchi S. Epidemiology of endometriosis and its comorbidities. Eur. J. Obstet. Gynecol. Reprod. Biol. 2017;209:3–7. doi: 10.1016/j.ejogrb.2016.04.021. - DOI - PubMed
    1. Fassbender A., Vodolazkaia A., Sounders P., Lebovic D., Waelkens E., De Moor B., D’Hooghe T. Biomarkers of Endometriosis. Fertil. Steril. 2013;99:1135–1145. doi: 10.1016/j.fertnstert.2013.01.097. - DOI - PubMed
    1. Committee of the American Society for Reproductive Medicine Endometriosis and infertility: A committee opinion. Fertil. Steril. 2012;98:591–598. doi: 10.1016/j.fertnstert.2012.05.031. - DOI - PubMed

LinkOut - more resources